Skip to content

Study · Animal study (in vivo) · mouse · 1976

3 results

[Biochemical characterization of a circulating thymic factor].

Bach JF, Dardenne M, Pleau JM, Rosa J

Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles1 Nov 1976Cited by 4 (Europe PMC)

PMID827370 (opens in a new tab)PepBankPUB-00827370

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Activity measurement

    In mice, the synthetic serum thymic factor nonapeptide was active in the rosette assay at 0.1 ng per mouse.

    In plain wordsIn mice, synthetic serum thymic factor was active in the rosette assay at 0.1 ng per mouse.

    Outcome
    Not applicableIn vivo rosette assay activity
    Study

    mousen: not reported in source

    In vivo rosette assay
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    0.1 ng per MouseAs given in this study (mouse).

    Measurements

    Active dose
    0.1 ng per Mouse
    in vivo rosette assay

    Source sentences

    Summary
    A nonapeptide, synthesized on the basis of this sequence is active in the rosette assay used for the isolation of the biological product, both in vitro (10(-15) M) and in vivo (0.1 ng per Mouse).
  2. 02LabIn vitro (cells)Activity measurement

    In an in vitro rosette assay, the synthetic serum thymic factor nonapeptide was active at 10(-15) M.

    In plain wordsIn lab tests, synthetic serum thymic factor was active in the rosette assay at 10(-15) M.

    Outcome
    Not applicableIn vitro rosette assay activity
    Study

    n: not reported in source

    In vitro rosette assay
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    10(-15) MAs given in this study.

    Source sentences

    Summary
    A nonapeptide, synthesized on the basis of this sequence is active in the rosette assay used for the isolation of the biological product, both in vitro (10(-15) M) and in vivo (0.1 ng per Mouse).

Studies that did not test the peptide alone1

In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymulin (serum thymic factor).

  1. 03LabNot a test of Thymulin (serum thymic factor) aloneIn vitro (cell-free)Other

    The serum thymic factor isolated from pig serum had the sequence Gln-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn.

    In plain wordsIn lab tests, the factor from pig serum had the sequence Gln-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn.

    Outcome
    Not applicableAmino-acid sequence
    Study

    pign: not reported in source

    Factor isolated from pig serum
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Its amino-acid sequence has been determined by Edman technique, modified by Gray: Gln-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn.
    1 context sentence
    Summary · context
    A serum thymic factor has been isolated from pig serum.

    In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymulin (serum thymic factor).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.